Advertisement
Advertisement
ELV
Elevance Health, Inc.
413.75
USDSponsored
+0.15
+0.04%
Nov 03, 16:00 UTC -5
Closed
Pre-Market
415.72
+1.97
+0.48%
Elevance Health, Inc. (ELV) Earnings
ELV Earnings Reports
Positive Surprise Ratio
ELV beat 33 of 43 last estimates.
77%
Next Report
Date of Next Report
Jan 26, 2027
Estimate for Q4 26 (Revenue/ EPS)
$49.74B
/$2.08
Implied change from Q3 26 (Revenue/ EPS)
-1.39%
/-70.24%
Implied change from Q4 25 (Revenue/ EPS)
+0.87%
/-37.54%
Elevance Health, Inc. earnings per share and revenue
On Oct 21, 2026, ELV reported earnings of 6.99 USD per share (EPS) for Q3 26, beating the estimate of 4.72 USD, resulting in a 47.81% surprise. Revenue reached 50.44 billion, compared to an expected 49.63 billion, with a 1.64% difference. The market reacted with a -1.37% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 2.08 USD, with revenue projected to reach 49.74 billion USD, implying an decrease of -70.24% EPS, and decrease of -1.39% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Revvity, Inc.
Report Date
Nov 03, 2026 For Q3 26
Estimate
$1.32
Actual
$1.38
Surprise
+4.09%
BrightSpring Health Services, Inc. Common Stock
Report Date
Oct 30, 2026 For Q3 26
Estimate
$0.48
Actual
$0.54
Surprise
+12.20%
PACS Group, Inc.
Report Date
Nov 03, 2026 For Q3 26
Estimate
$0.59
Actual
$0.63
Surprise
+5.04%
Sotera Health Company Common Stock
Report Date
Nov 03, 2026 For Q3 26
Estimate
$0.27
Actual
$0.28
Surprise
+6.89%
CareDx, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.25
Actual
$0.70
Surprise
+178.44%
Organon & Co.
Report Date
Oct 30, 2026 For Q3 26
Estimate
$0.94
Actual
$0.94
Surprise
-0.73%
Pediatrix Medical Group, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.66
Actual
$0.72
Surprise
+7.61%
Establishment Labs Holdings Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.31
Surprise
-18.41%
COMPASS Pathways Plc - ADR
Report Date
Nov 03, 2026 For Q3 26
Estimate
-$0.45
Actual
-$0.31
Surprise
+31.96%
Alignment Healthcare, Inc. Common Stock
Report Date
Oct 29, 2026 For Q3 26
Estimate
-$0.03
Actual
-$0.04
Surprise
-12.36%
FAQ
What were Elevance Health, Inc.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Elevance Health, Inc. reported EPS of $6.99, beating estimates by 47.81%, and revenue of $50.44B, 1.64% above expectations.
How did the market react to Elevance Health, Inc.'s Q3 2026 earnings?
The stock price moved down -1.37%, changed from $440.18 before the earnings release to $434.13 the day after.
When is Elevance Health, Inc. expected to report next?
The next earning report is scheduled for Jan 26, 2027.
What are the forecasts for Elevance Health, Inc.'s next earnings report?
Based on --
analysts, Elevance Health, Inc. is expected to report EPS of $2.08 and revenue of $49.74B for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.